Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keto-Mojo is a private metabolic health and medical device company focused on blood ketone and glucose monitoring for people following ketogenic or low-carbohydrate interventions and for healthcare practitioners managing metabolic health remotely. Founded in Napa Valley, California in 2017 by Dorian Greenow and Gemma Kochis, the company commercializes FDA-cleared ketone and glucose meters, disposable test strips, and companion software. Its product portfolio includes the GK+ and GKI meter systems and the MyMojoHealth data platform, which supports smartphone syncing, glucose-ketone tracking, Glucose Ketone Index calculation, and optional remote sharing with clinicians. The company also publishes extensive educational content for consumers and practitioners around ketogenic diets, diabetes, weight loss, neurological conditions, and broader metabolic health. Keto-Mojo is best characterized as a commercial-stage digital health and diagnostics business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keto-Mojo.